The U.S. healthcare system faces staggering costs from chronic diseases,
This is where ODMachine (ODM), a cutting-edge Israeli company, steps in. By leveraging Artificial Intelligence (AI) and Big Data, ODM revolutionizes disease management, offering the U.S. an opportunity to save tens of billions of dollars annually.
Diabetes as a Case Study – A $33 Billion Annual Savings Opportunity.
Diabetes is a pressing public health concern in the U.S., impacting millions of lives and driving significant economic burdens. Current data indicates that 38.1 million adults aged 18 years or older — or 14.7% of all U.S. adults — have diabetes. Early diagnosis, effective treatment, and rigorous control are critical to preventing complications and reducing costs. Raising awareness and promoting proactive care are essential to improving outcomes and mitigating the long-term impacts of this disease.
Particularly, Type 2 Diabetes (T2DM), imposes an annual economic burden of $413 billion. Half of all diabetic patients in the U.S. are uncontrolled, significantly increasing medical expenses and productivity losses.
Currently, 50% of U.S. diabetics are uncontrolled, leading to higher medical costs ($13,000 per year per uncontrolled patient vs. $8,700 per controlled patient).
This translates to an extra $4,300 per year per uncontrolled patient.
The total annual cost for uncontrolled diabetics: $248 billion per year, compared to $166 billion if all the uncontrolled patients were to be controlled.
If the proportion of controlled diabetics increased by just 20%, the U.S. healthcare system could save up to $33 billion annually! This could be achieved by the end of a five-year period through the implementation of ODM’s AI healthcare platform. Undoubtedly, these improvements can be sustained over the following ten years, resulting in cumulative savings of approximately $330 billion. Moreover, further enhancements, or increasing healthcare costs for uncontrolled patients, could drive total savings even higher. This robust economic case supports the long-term implementation of ODM’s AI healthcare platform.
Israel’s Proven Model – A Roadmap for U.S. Success
In Israel, a dynamic national reporting system transformed diabetes management. From 2006 to 2024, the proportion of well-controlled diabetics rose from below 50% to 73%, without financial incentives – just through better data and provider accountability.
ODM offers the U.S. the same proven model – efficient, data-driven, and ready for rapid implementation.
Hypertension as a Case Study – A $21 Billion Annual Savings Opportunity
Hypertension is a is a leading cause of cardiovascular disease and a major public health concern in the U.S., affecting nearly 123 million adults – about 47% of the adult population. The healthcare cost attributable to hypertension in 2024 is estimated to be $254 billion. Often called the “silent killer,” it frequently goes undiagnosed, increasing the risk of serious complications like heart disease and stroke. Early detection, effective treatment, and improved awareness are essential for managing the condition, preventing long-term morbidity and mortality, and reducing healthcare costs. Achieving and maintaining blood pressure control is not just about treatment but about safeguarding overall health and alleviating a significant burden on the healthcare system. The following summary provides data on the prevalence, control status, and economic impact of hypertension in the U.S.A.
Currently, 56% of hypertensive patients in the U.S. have uncontrolled blood pressure, leading to $2,900 in added medical costs per person compared to those with controlled hypertension.
The total annual added cost burden of hypertension on the US healthcare system is estimated at approximately $200 billion per year.
The percentage of adults with uncontrolled hypertension in the world’s developed countries is approximately 50% ( for example Germany, France and Australia).
If the proportion of uncontrolled hypertensive patients can be lowered to 50%, the U.S. healthcare system could save up to $21 billion annually! This could be achieved by the end of a five-year period through the implementation of ODM’s AI healthcare platform.
Undoubtedly, these improvements can be sustained over the following ten years, resulting in cumulative savings of approximately $210 billion.
Moreover, further enhancements, or increasing healthcare costs for uncontrolled patients, could drive total savings even higher. This robust economic case supports the long-term implementation of ODM’s AI healthcare platform.
ODM’s AI-Powered Solution – Smarter Healthcare, Lower Costs
With ODM, the U.S. can implement:
✅ A real-time national disease registry to track and improve chronic disease management.
✅ A performance-based reporting system to enhance healthcare provider efficiency.
✅ A scalable, cost-effective solution already proven to drive massive healthcare savings.
Strategic Opportunity for Healthcare Reform
With a potential $54 billion annual savings on the treatment of just two chronic diseases, diabetes and hypertension, ODM is not just a healthcare solution – it’s an economic game-changer. Lowering healthcare costs while improving patient outcomes is a win-win for the American people and the U.S. economy.
Now is the time to bring ODM’s AI-powered healthcare transformation to the U.S. and revolutionize chronic disease management, reduce national healthcare costs, and improve millions of lives.
